Azerbaijan Pharmaceuticals Tenders

Azerbaijan's pharma market is on the rise, reaching $162.9 million in 2023 and expected to grow at 5.15% annually. That's a promising $209.4 million by 2028!
This growth is driven by an increasing population, rising incomes, and government focus on improving healthcare.
Generics dominate the market, but patented drugs are gaining ground, especially for innovative treatments.

The Azerbaijani government is a key player, accounting for 30% of the pharma market.
They prioritize affordability and quality, aiming for the best value for their money.
Procurement is centralized through the Ministry of Health, which uses open tenders to select suppliers.

The government's shopping list includes essential meds like:
Prescription drugs for diabetes, heart disease, and other chronic conditions
Vaccines to keep the population immunized
Blood products for emergencies and transfusions
They also invest in research and development to boost domestic production and reduce reliance on imports.

The Ministry of Health calls the shots, setting policies and guidelines for government pharma purchases.
The State Committee for Standardization and Metrology ensures all drugs and medical devices meet quality and safety standards.
The Medical Products Agency regulates and monitors the entire pharmaceutical market.

Local and international companies compete for government contracts. Some top winners include:
AzeriMed, a leading domestic pharmaceutical manufacturer
Stada CIS, a regional subsidiary of the German pharma giant
TEVA, another international player known for affordable generics
Abbott, the American company known for medical devices and diagnostics

Tags -
Azerbaijan pharmaceutical tenders, Azerbaijan pharmaceuticals bids contracts, Azerbaijan pharmaceutical government tenders, Azerbaijan pharmaceutical global tenders, Azerbaijan free pharmaceutical tenders, Azerbaijan drugs tenders, Azerbaijan medicine tenders, Azerbaijan generic medicine tenders